Highlights:
- Most patients improved within one month: Nearly 94% of participants reported some level of improvement after completing the initial Sound Resonance Therapy phase.
- Large symptom reductions were common: Half of patients experienced a 50% or greater reduction in fibromyalgia impact scores after one month.
- Clinically meaningful change: Another 23% achieved at least a 25% reduction in FIQ — meeting thresholds often used to define effective treatment response.
- Structured, multi-phase approach: Improvements were observed following a program that combined vibro-acoustic sessions, guided reflection, and longer-term integration support.
Fibromyalgia can be exhausting — persistent pain, disrupted sleep, and day-to-day symptoms that are often difficult to manage. A retrospective analysis by Cogan et al. explored an innovative, non-invasive approach called Sound Resonance Therapy (SRT). This method combines vibro-acoustic sound sessions with structured reflection and follow-up support, with the goal of helping people shift how their bodies process pain and stress.
Study Overview
Researchers reviewed outcomes from 159 fibromyalgia patients treated between June 1996 and May 2004. Participants ranged from 15 to 68 years old (mean age 47, SD 10), and 8.8% were men.
A total of 131 patients completed a pre-treatment Fibromyalgia Impact Questionnaire (FIQ) and at least one post-treatment FIQ. Of these, 128 had 1-month follow-up data. Longer-term FIQ follow-up was also available for subsets of participants at 6 months (n=56) and 12 months (n=53).
Key Findings (1-Month Outcomes)
Results at approximately one month into the protocol were encouraging:
- Widespread improvement: 93.7% (123/131) showed some improvement at 1 month.
- Meaningful FIQ change: The median decrease in FIQ was approximately 26 points after one month of treatment.
- Large shifts were common: 50% of patients achieved a 50% or greater reduction in total FIQ score, and another 23% achieved at least a 25% reduction.
These findings suggest that, for many patients, SRT was associated with noticeable improvements in fibromyalgia-related symptom burden within the first month.
Figure 1. Most Participants Reported Meaningful Improvement After One Month of Sound Resonance Therapy. This figure shows the percentage of fibromyalgia patients who experienced improvement one month after Sound Resonance Therapy. Nearly 94% of participants showed some level of improvement. Among them, at least 50% of patients experienced a 50% or greater reduction in symptom impact, while at least 23% experienced a 25% or greater reduction based on Fibromyalgia Impact Questionnaire (FIQ) scores. Together, these results highlight that a large proportion of participants experienced substantial, clinically meaningful improvements within the first month of treatment.
Therapeutic Approach: A Three-Phase Model
SRT followed a structured, multi-phase protocol:
- SRT Phase (10 days)
Patients completed 16–20 vibro-acoustic sound sessions over 10 days (twice daily). During this phase, participants also reflected on their experience and kept notes or journal entries.
- Psycho-coaching Phase (2–4 weeks)
Participants engaged in daily psychotherapy sessions, using earlier reflections to explore emotional and physical stressors that may influence symptoms.
- Integration Phase (up to ~11 months)
The final phase included biweekly coaching to support real-life application and long-term habit integration.
Takeaway
This retrospective analysis suggests that Sound Resonance Therapy may be associated with substantial early improvements in fibromyalgia impact as measured by the FIQ — particularly at the 1-month checkpoint, where most patients improved and many showed large percentage reductions. Follow-up questionnaires were collected at 6 and 12 months for a subset of participants, supporting continued interest in longer-term outcomes and future research.
Reference: Cogan J, Camus M, Saucier JF, Arsenault P, Demers J. A new application of sound resonance technology therapy for the treatment of fibromyalgia: a retrospective analysis. Complement Ther Clin Pract. 2006;12(3):206-212. doi:10.1016/j.ctcp.2006.04.001